Astrazeneca (AZN) closed at $85.31, up 1.98% from the previous day, outperforming the S&P 500. The stock gained 2.29% in the past month. Earnings per share is projected to increase by 9.62%, with revenue estimated at $14.86 billion. Analysts have a Zacks Rank of #3 (Hold) on AZN. Moving forward, the company’s valuation metrics show potential for growth. The Medical – Biomedical and Genetics industry, where AZN operates, has a Zacks Industry Rank of 74, in the top 30% of industries. Quantum Computing is emerging as the next big tech revolution, with companies like Microsoft and Google integrating it. Investors can capitalize on this trend by exploring 7 stocks recommended in a report by Senior Stock Strategist Kevin Cook. This innovative technology could offer significant gains for investors willing to seize the opportunity.

Read more at Nasdaq: Astrazeneca (AZN) Rises Higher Than Market: Key Facts